How Do You Know If You Have Mold in Your Lungs?

There is no single symptom that tells you mold has taken hold in your lungs. The symptoms of a pulmonary fungal infection, whether it is a cough that lingers for weeks, chest tightness, coughing up blood, or recurring fevers, overlap heavily with pneumonia, tuberculosis, and even lung cancer. Confirming mold in the lungs requires medical testing: imaging, blood work, and sometimes collecting a sample directly from the airways. What makes the question tricky is that the type of fungal lung disease you might develop, and how urgently it needs treatment, depends almost entirely on your immune status and the species of mold involved.

Symptoms That Should Raise Suspicion

Fungal lung infections share a frustrating trait: their symptoms look like dozens of other respiratory conditions. A persistent cough, shortness of breath, chest pain, and fever are the usual complaints, and none of them points specifically to mold. In a study of patients with pulmonary mucormycosis, about 70% had fever, 70% had cough, roughly half produced sputum, and about 40% coughed up blood.¹ Aspergilloma, where a fungal ball grows inside an existing lung cavity, produces a similar list: coughing up blood, chest pain, shortness of breath, cough, and fever, all described as “non-specific.”²

In allergic forms of fungal lung disease, the picture shifts slightly. Allergic bronchopulmonary aspergillosis (ABPA) tends to show up in people who already have asthma or cystic fibrosis. It causes worsening wheezing, mucus plugging, and declining lung function that does not respond well to standard asthma treatment.³ The clue is often that your breathing deteriorates in a way your usual medications cannot explain. Indoor mold exposure in general can cause nasal congestion, eye irritation, and mucous membrane symptoms through several mechanisms, from straightforward allergy to irritant reactions to fungal spores and their metabolic byproducts.⁴

The bottom line on symptoms: a cough that will not quit, unexplained fevers, bloody sputum, or asthma that suddenly gets worse should prompt you to mention mold exposure to your doctor. None of these symptoms proves anything on their own, but they give a clinician reason to start testing.

Who Is Most at Risk

Your immune system is the single biggest variable. Healthy lungs encounter mold spores constantly and clear them without incident. Certain fungal species can cause problems even in people with normal immunity, but the most serious infections, the invasive kind that can be life-threatening, overwhelmingly strike people whose immune defenses are compromised. The key risk factors include diabetes, chronic lung disease, blood cancers, and having received a solid organ transplant.⁵ HIV, influenza, COVID-19, and treatments that suppress the immune system (chemotherapy, high-dose steroids, anti-rejection drugs) also increase vulnerability.⁶

People with pre-existing lung cavities, from past tuberculosis, sarcoidosis, or emphysema, face a particular risk of aspergilloma, where Aspergillus colonizes the damaged space and grows into a mass.⁷ If you have had structural lung damage and develop new respiratory symptoms, a fungal cause is worth investigating. Pulmonary mucormycosis, a rarer and more aggressive infection, predominantly targets people with uncontrolled diabetes.⁸

That said, immune status is not the whole story. Some fungal species found in specific geographic regions, including histoplasmosis, coccidioidomycosis, and blastomycosis, cause lung infections in otherwise healthy people.⁹ Geography and exposure history matter. If you have been doing construction work, spelunking, farming, or cleaning out old buildings in endemic areas, your risk goes up regardless of how healthy your immune system is.

The Different Forms Mold Takes in the Lungs

Not all fungal lung problems are the same disease. The way mold affects you depends on the interplay between the fungal species, the dose of exposure, and your body’s response. It helps to understand the broad categories, because the diagnostic workup and urgency differ for each one.

Allergic and Hypersensitivity Reactions

In ABPA, the mold itself does not invade your tissues. Instead, your immune system overreacts to Aspergillus fumigatus growing in the airway mucus. This triggers a cascade of inflammation, bronchospasm, and over time, permanent airway damage called bronchiectasis.³ ABPA is diagnosed through a combination of clinical findings, imaging, and blood tests that show elevated IgE antibody levels and sensitization to Aspergillus.¹⁰ Hypersensitivity pneumonitis, or “farmer’s lung,” is a related but distinct condition where repeated inhalation of mold antigens (from moldy hay, grain dust, or compost) causes deep lung inflammation. It is frequently misdiagnosed as an unexplained interstitial lung disease because clinicians do not always ask about exposure history.¹¹

Fungal Balls and Chronic Pulmonary Aspergillosis

An aspergilloma is a clump of fungal hyphae, mucus, and debris that grows inside a pre-existing cavity in the lung. It does not invade surrounding tissue; it just sits there, sometimes for years, occasionally causing life-threatening bleeding. Diagnosing it requires both imaging evidence of the mass and lab confirmation of Aspergillus involvement.² On a CT scan, the classic finding is a rounded mass inside a cavity that shifts when the patient changes position. This chronic form of aspergillosis tends to smolder rather than erupt, which means it can go undetected for a long time.

Invasive Pulmonary Infections

Invasive pulmonary aspergillosis is the most dangerous form. The fungus penetrates lung tissue and blood vessels, and it can spread to other organs. It moves fast in severely immunocompromised patients, and delays in diagnosis worsen survival. A landmark trial found that patients treated with voriconazole had a 71% survival rate at 12 weeks compared to 58% for those given the older standard drug, reinforcing how much early, targeted treatment matters.¹² Invasive mucormycosis is similarly aggressive and can be fatal even with prompt antifungal therapy.⁸

How Doctors Actually Diagnose Fungal Lung Infections

Because symptoms are unhelpful on their own, diagnosis leans on a combination of imaging, blood markers, and direct sampling of the lungs. Your doctor will typically move through these tools in roughly that order, starting with the least invasive.

Chest Imaging

A CT scan is the starting point. Different fungal diseases leave recognizable patterns. Invasive aspergillosis often produces a “halo sign,” where a ground-glass haze surrounds a dense nodule on the scan. Mucormycosis, by contrast, tends to produce a “reversed halo sign,” a ring of dense tissue around a hazy center. In patients with severely weakened immune systems, these CT patterns are strong pointers toward an invasive mold infection.¹³ Other patterns include cavities, consolidation (areas where the lung looks solid rather than airy), and masses. None of these are unique to fungal disease, which is why imaging alone is not enough. But it narrows the possibilities and guides what to test next.

Blood and Biomarker Tests

Two biomarkers are commonly used when invasive aspergillosis is suspected: galactomannan (GM) and beta-D-glucan (BDG). Both are components of fungal cell walls that leak into the blood or lung fluid during active infection. Their performance depends heavily on where the sample comes from. Testing galactomannan from fluid washed directly from the airways (bronchoalveolar lavage fluid, or BALF) catches far more cases than testing blood serum. One study found BALF galactomannan had roughly 78% sensitivity compared to about 48% for serum galactomannan.¹⁴ The serum BDG test had extremely low sensitivity in that study and was not recommended as a first-line tool. However, in a different population of critically ill patients with blood cancers, the BDG test performed much better, catching 90% of probable invasive aspergillosis cases while GM missed 70% of them.¹⁵ The takeaway: no single blood test is reliable in every patient group, and the results have to be interpreted alongside imaging and clinical context.

For ABPA, the blood tests are different. Doctors look for a markedly elevated total IgE level and evidence that your immune system is specifically sensitized to Aspergillus proteins. These immunological markers, combined with imaging and symptoms, form the diagnostic criteria.¹⁰

Bronchoscopy and Direct Sampling

When blood tests and imaging are not conclusive, clinicians often turn to bronchoscopy, a procedure where a thin flexible scope is passed into the airways to collect fluid or tissue. The fluid rinse (bronchoalveolar lavage) is then cultured for fungi or tested with molecular tools. In one study of fungal infections, standard sputum samples were culture-positive only 5% of the time, while bronchoscopy cultures identified the fungus in 85% of cases.¹⁶ For blastomycosis, BAL produced diagnostic yields above 87%.¹⁷ This is why doctors often push for bronchoscopy rather than relying on sputum you cough up at home: the difference in detection rates is enormous.

Traditional culture can take days and sometimes fails when bacteria overgrow the sample. Molecular methods, including PCR-based detection, are changing the game. One study found that PCR identified fungi in over a third of BAL specimens that came back negative on culture.¹⁸ Newer approaches like metagenomic next-generation sequencing have shown sensitivity around 80-84% for pulmonary fungal infections, roughly double the sensitivity of conventional tests in the same patients.¹⁹ Digital droplet PCR assays targeting specific pathogens like Aspergillus, Cryptococcus, and Pneumocystis have also shown high accuracy in validation studies.²⁰ These tools are not universally available yet, but they are becoming more common at larger medical centers and are especially useful when culture fails to grow anything.

When Mold Looks Like Cancer on a Scan

One of the more unsettling things about fungal lung infections is that they can look exactly like lung cancer on imaging. Fungal masses can form spiculated nodules (the kind with spiky edges that radiologists associate with malignancy), light up on PET scans the same way tumors do, and even grow over time.²¹ Chronic forms of aspergillosis are especially prone to mimicking cancer because they tend to appear in smokers with emphysema, exactly the population already at high risk for lung malignancy.²²

This overlap causes real harm. Some patients undergo biopsies or even surgery for what is assumed to be cancer, only for the pathology to come back showing fungal infection. Conversely, a fungal infection can be mistaken for something benign, delaying antifungal treatment. If you are told you have a suspicious lung nodule and you have risk factors for mold exposure, asking your care team to consider a fungal cause is reasonable and sometimes revelatory.

Fungi You Already Breathe Every Day

It is worth knowing that fungal DNA is a normal finding in healthy lungs. The “lung mycobiome” includes fungi that land in the airways through ordinary breathing and are cleared without issue, fungi that are part of the broader human microbiome, and a small number of species that have specifically evolved to live in lung tissue. Species of Cladosporium, Aspergillus, and Penicillium are among the most commonly inhaled, while Candida and Malassezia drift in from the skin. Pneumocystis is an example of a fungus that appears to have co-evolved with mammalian lungs and normally causes no harm unless the immune system collapses.²³

This means that merely detecting fungal DNA or even growing a mold from a lung sample does not automatically prove disease. Aspergillus, for instance, can be an incidental inhaled bystander or a deadly invasive pathogen, depending on the host. Clinicians have to weigh whether the fungus they find is causing the symptoms or just passing through. Context, meaning your symptoms, immune status, imaging findings, and the quantity of fungus detected, is what separates a normal finding from a diagnosis.

Occupational and Environmental Exposures Worth Mentioning to Your Doctor

One of the most common reasons fungal lung disease gets missed is that nobody asks about exposure. Farmer’s lung was described as far back as the 1950s as a granulomatous lung inflammation triggered by inhaling mold from hay and grain,²⁴ yet it is still frequently misdiagnosed today because clinicians may not think to ask about farming, composting, or animal husbandry.¹¹ The same goes for construction workers disturbing old buildings, gardeners turning compost, and anyone cleaning up after water damage in a home.

Fungal spores behave differently depending on the species. Some are thermophilic, meaning they thrive at human body temperature and can act simultaneously as allergens, irritants, and true pathogens. Aspergillus and Penicillium fall into this category. Other common indoor molds, such as Cladosporium and Alternaria, can trigger allergic and irritant reactions in the airways but do not typically invade lung tissue.²⁵ Knowing what you were exposed to, and communicating that to your doctor, can substantially shorten the diagnostic journey. If you have been around visible mold, musty environments, or heavy dust in agricultural or demolition settings and then develop persistent respiratory symptoms, lead with that information at your appointment. It may be the detail that steers testing in the right direction.